Stockscreener 앱 받기
9.73
1.25%
0.12
시간 외 거래:
9.94
0.21
+2.16%
전일 마감가:
$9.61
열려 있는:
$9.75
하루 거래량:
1.84M
Relative Volume:
1.60
시가총액:
$766.43M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+7.63%
1개월 성능:
-18.71%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$9.66
$10.57
1주일 범위
$8.98
$11.29
52주 변동 폭
$5.33
$14.69
Niagen Bioscience Inc Stock (NAGE) Company Profile
명칭
Niagen Bioscience Inc
전화
310-388-6706
주소
10900 WILSHIRE BLVD, LOS ANGELES
NAGE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NAGE
Niagen Bioscience Inc
|
9.73 | 740.43M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Niagen Bioscience Inc Stock (NAGE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-27 | 개시 | Canaccord Genuity | Buy |
| 2022-08-16 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-08-11 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2022-03-08 | 개시 | ROTH Capital | Buy |
| 2019-10-16 | 개시 | Oppenheimer | Outperform |
| 2019-02-14 | 개시 | B. Riley FBR | Buy |
| 2017-11-27 | 재개 | H.C. Wainwright | Buy |
| 2017-09-25 | 개시 | Ladenburg Thalmann | Buy |
| 2017-01-03 | 개시 | Rodman & Renshaw | Buy |
모두보기
Niagen Bioscience Inc 주식(NAGE)의 최신 뉴스
Real time scanner hits for Niagen Bioscience Inc. explainedRisk Balanced Picks for Safer Trading - Newser
News impact scoring models applied to Niagen Bioscience Inc.In-Depth Stock Trading Volume Analysis - Newser
Niagen Bioscience, Inc. (NASDAQ:NAGE) Receives $13.22 Consensus Price Target from Analysts - MarketBeat
Niagen Bioscience Shares Climb Following Exclusive License for Parkinson’s Therapy - MSN
Roth Capital Cuts Earnings Estimates for Niagen Bioscience - MarketBeat
Risk adjusted return profile for Niagen Bioscience Inc. analyzedSafe and Scalable Return Strategy Blueprint - Newser
Can Niagen Bioscience Inc. rally from current levelsLow Risk Strategy with Smart Entry Zones - Newser
Will a bounce in Niagen Bioscience Inc. offer an exitProven Trading System with Consistent Gains - Newser
Niagen Bioscience (NASDAQ:NAGE) Shares Gap Up Following Strong Earnings - MarketBeat
Niagen Bioscience, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - simplywall.st
Earnings Beat: Niagen Bioscience, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - Yahoo Finance
Niagen Bioscience, Inc. (NASDAQ:NAGE) Given Average Recommendation of “Buy” by Brokerages - Defense World
Niagen Bioscience (NASDAQ:NAGE) Shares Gap Up Following Better-Than-Expected Earnings - Defense World
Should you wait for a breakout in Niagen Bioscience Inc.Free Fundamental Growth Stock Analysis - Newser
Niagen Bioscience Reports Strong Q2 Sales Growth - The Globe and Mail
Niagen Bioscience: Q2 Earnings Snapshot - New Haven Register
Niagen Bioscience (NASDAQ:NAGE) Cut to Buy at Wall Street Zen - MarketBeat
Niagen Bioscience shares rise 21.91% premarket after Q2 sales beat estimates. - AInvest
Earnings call transcript: Niagen Bioscience Q2 2025 earnings beat expectations By Investing.com - Investing.com Canada
Niagen Bioscience, Inc. Reports Second Quarter 2025 Financial Results and Increases Full Year Outlook - BioSpace
Niagen Bioscience Reports Strong Q2 Growth and Outlook - TipRanks
Niagen Bioscience shares rise 24.88% after-hours after Q2 sales beat estimates. - AInvest
Niagen NAGE Q2 2025 Earnings Call Transcript - AOL.com
Niagen Bioscience (NAGE) Q2 Earnings and Revenues Surpass Estimates - ca.finance.yahoo.com
Niagen Bioscience Q2 2025 presentation: Revenue jumps 37%, ingredient sales surge 135% - Investing.com Australia
Niagen Bioscience earnings beat by $0.02, revenue topped estimates - Investing.com Canada
Niagen Bioscience Inc reports results for the quarter ended June 30Earnings Summary - TradingView
What You Can Learn From Niagen Bioscience, Inc.'s (NASDAQ:NAGE) P/S After Its 28% Share Price Crash - simplywall.st
Niagen Bioscience reports Q2 EPS 4c, consensus 1c - TipRanks
Niagen Bioscience shares fall 3.53% premarket ahead of CEO's participation in Canaccord Genuity's 45th Annual Growth Conference. - AInvest
Niagen Bioscience Inc expected to post earnings of 1 cent a shareEarnings Preview - TradingView
Niagen Bioscience to Present at Canaccord Genuity’s 45th Annual Growth Conference - BioSpace
Niagen Bioscience (NASDAQ:NAGE) Stock Rating Lowered by Wall Street Zen - Defense World
What is the dividend policy of Niagen Bioscience Inc. stockDiscover high-impact investment opportunities - Jammu Links News
What makes Niagen Bioscience Inc. stock price move sharplyTrend Reversal Watch with Entry Signals - Newser
Should I hold or sell Niagen Bioscience Inc. stock in 2025Get daily expert analysis on top stocks - Jammu Links News
What is Niagen Bioscience Inc. company’s growth strategyGet exclusive access to professional stock picks - Jammu Links News
Is Niagen Bioscience Inc. a growth stock or a value stockFree Predictions - Jammu Links News
Why is Niagen Bioscience Inc. stock attracting strong analyst attentionSuperior risk-adjusted returns - Jammu Links News
What are analysts’ price targets for Niagen Bioscience Inc. in the next 12 monthsHigh-profit stock alerts - Jammu Links News
How strong is Niagen Bioscience Inc. company’s balance sheetDiscover high-impact stocks for your portfolio - Jammu Links News
When is Niagen Bioscience Inc. stock expected to show significant growthUnlock powerful trading alerts for success - Jammu Links News
Niagen Bioscience (NASDAQ:NAGE) Shares Up 6%Here's Why - MarketBeat
UBS Reports Strong Q2 2025 Results Amid Integration and Regulatory Challenges - The Globe and Mail
Live market analysis of Niagen Bioscience Inc.Entry Timing with Downside Risk Analysis - Newser
What technical models suggest about Niagen Bioscience Inc.’s comebackChart Driven High Reward Trading Setup Presented - metal.it
Niagen Bioscience And Two Other High Growth Stocks With Strong Insider Ownership - Yahoo Finance
Can NAD+ really help with longevity? - AOL.com
Niagen Bioscience Subsidiary Signs Supply Agreement - TipRanks
Niagen Bioscience Inc (NAGE) 재무 분석
Niagen Bioscience Inc (NAGE)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):